Pdt Partners, LLC Omeros Corp Transaction History

Pdt Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.92 - $6.28 $111,442 - $364,510	-58,043 Reduced 35.2%	106,865 $294,000
Q1 2022 May 16, 2022	BUY	$5.07 - $7.2 $836,083 - $1.19 Million	164,908 New	164,908 $991,000
Q3 2021 Nov 15, 2021	SELL	$13.4 - $16.3 $259,960 - $316,220	-19,400 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.81 - $19.13 $287,314 - $371,122	19,400 New	19,400 $288,000
Q4 2020 Feb 16, 2021	SELL	$10.14 - $15.19 $185,562 - $277,977	-18,300 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.57 - $21.32 $175,131 - $390,156	18,300 New	18,300 $185,000

120

25.6M

228K

630K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $684M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.